Envoy Medical, Inc.(COCH)

Medical - Devices · White Bear Lake, MN

$0.67+0.02 (+3.04%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T13:41:49.225Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:41:49.225Z.

Quote observation: 2026-10-06T13:30:04.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,782,134
TTM operating cash flow · period ending 2026-06-30: -21,533,000

FMP input reference: fc92921354a3baefe39f76a6e19d16813aeb2294e32cc7e27fab112852b36d76

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

COCH Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

COCH Competitors' Price/OCF Ratio

COCH

Envoy Medical, Inc.

Current

Market Cap

$51.78M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs COCH

Market Cap

$51.23M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs COCH

Market Cap

$51.71M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs COCH

Market Cap

$53.01M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs COCH

Market Cap

$52.80M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs COCH

Market Cap

$50.51M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs COCH

Market Cap

$55.48M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs COCH

Market Cap

$50.67M

Price/OCF Ratio

2.08

TTM Avg

2.08

3Y Avg

4.49

5Y Avg

3.97

CNTB

Connect Biopharma Holdings Limited

vs COCH

Market Cap

$53.99M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs COCH

Market Cap

$49.84M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Envoy Medical, Inc. (COCH)	$51.78M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.23M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$51.71M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$53.01M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.80M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$50.51M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$55.48M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$50.67M	2.08	2.08	4.49	3.97
Connect Biopharma Holdings Limited (CNTB)vs ›	$53.99M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$49.84M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

COCH Price/OCF Ratio Metrics

COCH Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics